IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole-Reference-Cited by-同舟云学术

IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole

Published:2023-12-01 Issue:1 Volume:15 Page:1-7
ISSN:2229-5178
Container-title:Indian Dermatology Online Journal
language:en
Short-container-title:

Author:

Patel Nayankumar H.¹,Sardana Kabir²,Shenoy Manjunath M.³,Rengasamy Madhu⁴,Khurana Ananta²,Ghate Sunil⁵,Venkata Chalam Konakanchi⁶,Marfatiya Yogesh⁷,Bhunia Deblina⁸,Jayaraman Jyothi⁹,Das Anupam¹⁰,Jain Akshay Kumar¹¹

Affiliation:

1. Department of DVL, GCS Medical College Hospital and Research Centre, Ahmedabad, Gujarat, India

2. Department of Dermatology, Dr. Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India

3. Department of DVL, Yenepoya Medical College, Mangalore, Karnataka, India

4. Department of DVL, Madras Medical College, Chennai, Tamil Nadu, India

5. Dr. Ghate’s Skin, Hair and LASER Centre, Mumbai, Maharashtra, India

6. Government Medical College, Srikakulam, Andhra Pradesh, India

7. SBKS MI and RC, Piparia, Waghodia, Vadodara, Gujarat, India

8. M.G.M. Medical College, Kishanganj, Bihar, India

9. Department of Dermatology, Father Muller Medical College, Manglore, Karnataka, India

10. Department of DVL, KPC Medical College and Hospital, Kolkata, West Bengal, India

11. GMC, Kota, Rajasthan, India

Abstract

Abstract Itraconazole (ITZ) has been the mainstay of oral antifungal treatment for the current epidemic of recalcitrant dermatophytosis (RD) in India. Recently, a newer formulation of ITZ, super bioavailable itraconazole (SUBA-ITZ), is made available in the market by many pharmaceutical companies. It is important for dermatologists to understand the pharmacokinetic properties of SUBA-ITZ vis-a-vis conventional pellet formulation to use it effectively and safely. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) has established a special interest group for recalcitrant dermatophytosis (SIG-RD) to strengthen research, continuing medical education, and industry collaboration on the subject. This position statement on SUBA-ITZ by SIG-RD is an attempt to address current pieces of evidence and the position of this new formulation in the management of RD.

Publisher

Medknow

Reference27 articles.

1. Antifungal resistance in dermatophytes: Recent trends and therapeutic implications;Khurana;Fungal Genet Biol,2019

2. Mutation in the squalene epoxidase gene of Trichophyton interdigitale and Trichophyton rubrum associated with allylamine resistance;Rudramurthy;Antimicrob Agents Chemother,2018

3. A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: Genomic insights and resistance profile;Singh;Fungal Genet Biol,2019

4. Trichophyton indotineae sp. nov.: A new highly terbinafine-resistant anthropophilic dermatophyte species;Kano;Mycopathologia,2020

5. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene;Singh;Mycoses,2018